TB-500 Research Overview

An overview of TB-500, a synthetic version of thymosin beta-4, and its role in tissue repair research.

Scientific background / literature overview only. Discussion of published research does not describe the intended use of Novex Peptide products.

Novex Peptide Research Team28 July 2026 7 min read

TB-500 thymosin beta-4 tissue repair actin wound healing

Introduction

TB-500 is a synthetic peptide representing a fragment of thymosin beta-4 (Tβ4), a naturally occurring 43-amino acid peptide found in virtually all human and animal cells. TB-500 has been studied for its effects on tissue repair, wound healing, and cellular migration.

Mechanism of Action

Thymosin beta-4, and by extension TB-500, acts primarily through:

Actin Sequestration

Tβ4 is the primary G-actin binding protein in cells. By binding to G-actin, it regulates the polymerisation and depolymerisation of the actin cytoskeleton, which is essential for cell migration and tissue repair.

Cell Migration

Through its effects on the actin cytoskeleton, Tβ4 promotes the migration of keratinocytes, fibroblasts, and endothelial cells in vitro.

Anti-Inflammatory Effects

Research suggests Tβ4 may modulate inflammatory signalling, potentially reducing the production of pro-inflammatory cytokines.

Current Research

Cardiac Research

Animal studies have investigated Tβ4's effects on cardiac repair after myocardial infarction, including coronary vessel development and cardiac cell survival.

Dermal Wound Healing

Tβ4 has been studied in animal models of cutaneous wound healing, with research focusing on re-epithelialisation, collagen deposition, and inflammation reduction.

Corneal Research

Tβ4 has been investigated for its effects on corneal wound healing in animal eye injury models.

Chemical Properties

**Sequence:** Fragment of thymosin beta-4 (Tβ4), typically the N-terminal 17-amino acid sequence LKKTETQ

**Molecular weight:** Varies by specific fragment; full Tβ4 is 4,921 Da

**Origin:** Synthetic fragment of naturally occurring thymosin beta-4

Storage Considerations

Store lyophilised TB-500 at -20°C.

Protect from light and moisture.

Reconstituted solutions should be used immediately or aliquoted and frozen.

Testing Methods

TB-500 batches should be verified by:

RP-HPLC for purity (≥98% recommended)

Mass spectrometry for identity confirmation

Research Limitations

TB-500 is supplied for in vitro laboratory research and animal model studies only. Most published research is from animal or in vitro models. No clinical trials have confirmed efficacy in humans. No medical, therapeutic, or dosing claims are made. TB-500 is not approved for human therapeutic use by any regulatory authority.

References

1.Goldstein AL, et al. Thymosin Beta 4: A New Peptide. Expert Opin Biol Ther. 2010;10(1):19-26.
2.Crockford D. Thymosin Beta 4 and Wound Healing. Expert Rev Clin Pharmacol. 2008;1(3):413-420.
3.Bock-Marquette I, et al. Thymosin Beta 4 and Cardiac Repair. Ann N Y Acad Sci. 2010;1194:118-124.

Research use only. This article is for educational purposes only and does not constitute advice for any application involving human use. No medical claims are made.